Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (LXEO)

CUSIP: 52886X107

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+222,753
SEC-reported price per share
$3.38
Number of holders
8
Value change
+$734,551
Number of buys
4
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
83,158,200

Security key

52886X107

Report period

Q3 2026

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of LXEO - Lexeo Therapeutics, Inc. - Common Stock ($0.0001 par value) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 10%
BALYASNY ASSET MANAGEMENT L.P. 10%
Affinity Asset Advisors, LLC 8.4%
MONTANOVA CAPITAL, LLC 7.7%
Vestal Point Capital, LP 7.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
10%
$65,914,563
7,291,434 shares
+$10,720,599 28 Nov 2025
BALYASNY ASSET MANAGEMENT L.P.
13D/G 13F
Company
10%
$36,083,831
7,844,311 shares
+$3,073,568 30 Jun 2026
Affinity Asset Advisors, LLC
13D/G 13F
Company
8.4%
$30,704,600
6,674,913 shares
+$6,703,364 30 Jun 2026
MONTANOVA CAPITAL, LLC
13D/G 13F
SUVRETTA CAPITAL MANAGEMENT, LLC · Company
7.7%
$32,573,226
5,674,778 shares
$0 06 Apr 2026
Vestal Point Capital, LP
13D/G 13F
Company
7.5%
$27,338,885
4,117,302 shares
+$5,903,896 30 Sep 2025
CITADEL ADVISORS LLC
13D/G 13F
Kenneth Griffin · Company
7.4%
$40,851,767
5,498,219 shares
+$1,219,315 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
502,552
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
141
Q3 2026 holders
8
Holder diff
-133
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .